Dermira Inc buy melinda
Start price
06.12.17
/
50%
€21.95
Target price
29.12.17
€26.61
Performance (%)
14.95%
End price
29.12.17
€25.24
Summary
This prediction ended on 29.12.17 with a price of €25.24. The prediction had a final performance of 14.95%. melinda has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Dermira Inc | - | - | - | - |
| iShares Core DAX® | -1.212% | 1.925% | 17.589% | 68.786% |
| iShares Nasdaq 100 | -4.714% | -1.810% | 0.450% | 100.066% |
| iShares Nikkei 225® | -2.976% | -2.660% | 10.156% | 43.024% |
| iShares S&P 500 | -2.744% | -0.448% | 0.320% | 63.222% |
Comments by melinda for this prediction
In the thread Dermira Inc diskutieren
Olasacostat glasarétil (DRM01) Akne
Abgeschlossene Phase - 3 - Zulassungs kündigte am 5. Oktober 2017. Die Daten werden im ersten Quartal 2018 erhalten.
(Vom Mitglied beendet)